http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101996699-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0463 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0455 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0459 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0453 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-02 |
filingDate | 2012-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101996699-B1 |
titleOfInvention | Fluorine-18 and carbon-11 labeled radioligands for positron emission tomography (pet) imaging for lrrk2 |
abstract | Administering to a subject a compound of Formula I, Formula II or Formula III, or a pharmaceutically acceptable salt thereof; Infiltrating said compound into the tissue of an individual; And collecting a positron emission tomography (PET) image of the central nervous system (CNS) or brain tissue of the subject, wherein the compound comprises one or more C 11 or F 18 labels, wherein the PET of LRRK2 Imaging method. |
priorityDate | 2011-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 204.